Terms: = Kidney tumors AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
6 results:
1. Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.
Rossi S; Toschi L; Castello A; Grizzi F; Mansi L; Lopci E
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2310-2325. PubMed ID: 28815334
[TBL] [Abstract] [Full Text] [Related]
2. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
Duffy AG; Ulahannan SV; Makorova-Rusher O; Rahma O; Wedemeyer H; Pratt D; Davis JL; Hughes MS; Heller T; ElGindi M; Uppala A; Korangy F; Kleiner DE; Figg WD; Venzon D; Steinberg SM; Venkatesan AM; Krishnasamy V; Abi-Jaoudeh N; Levy E; Wood BJ; Greten TF
J Hepatol; 2017 Mar; 66(3):545-551. PubMed ID: 27816492
[TBL] [Abstract] [Full Text] [Related]
3. Monitoring peri-operative immune suppression in renal cancer patients.
Hase S; Weinitschke K; Fischer K; Fornara P; Hoda R; Unverzagt S; Seliger B; Riemann D
Oncol Rep; 2011 May; 25(5):1455-64. PubMed ID: 21369703
[TBL] [Abstract] [Full Text] [Related]
4. A study of proliferative activity, angiogenesis and nuclear grading in renal cell carcinoma.
Bhattacharyya NK; Chatterjee U; Sarkar S; Kundu AK
Indian J Pathol Microbiol; 2008; 51(1):17-21. PubMed ID: 18417843
[TBL] [Abstract] [Full Text] [Related]
5. Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case.
Ludvigsen L; Toxvaerd A; Mahdi B; Krarup-Hansen A; Bergenfeldt M
Surg Today; 2007; 37(12):1105-9. PubMed ID: 18030576
[TBL] [Abstract] [Full Text] [Related]
6. Trace elements distribution in renal cell carcinoma depending on stage of disease.
Dobrowolski Z; Drewniak T; Kwiatek W; Jakubik P
Eur Urol; 2002 Nov; 42(5):475-80. PubMed ID: 12429157
[TBL] [Abstract] [Full Text] [Related]